Ovarian Cancer Research Alliance (OCRA) is the world's leading organization combating ovarian and all gynecologic cancers through groundbreaking research, impactful advocacy, and unparalleled patient support while forging new paths in prevention, education, and awareness. As the largest global charity devoted to ovarian and related gynecologic cancer research, OCRA has invested $128 million in ovarian and related gynecologic cancer research initiatives since inception.

OCRA’s commitment to the most promising scientific research is funding discoveries, creating new treatments, and hastening desperately needed breakthroughs. We are the voice for the gynecologic cancer community, working with legislators to ensure federal research and education, drug and diagnostic safety, and access to high-quality care are protected on Capitol Hill. Our programs provide support for patients and their families when and where they need it most.

Visit ocrahope.org to learn more.